J. Xie et al. / Carbohydrate Research 340 (2005) 481–487
485
1.2.6. (20,40-Di-O-acetyl-60-azido-30-O-benzyl-60-deoxy-
b-D-glucopyranosyl)-ethene (7b). Rf 0.44 (1:2 EtOAc–
cyclohexane); H NMR (CDCl3, 250 MHz) d 7.34–7.23
(m, 5H, Ph), 5.83–5.69 (m, 1H, CH@), 5.39–5.24 (m,
2H, CH2@), 5.02 (t, J 9.5 Hz, 1H, H-20), 4.97 (t, J
9.5 Hz, 1H, H-40), 4.62 (s, 2H, CH2–Ph), 3.81 (dd, J
9.7, 6.8 Hz, 1H, H-10), 3.72 (t, J 9.3 Hz, 1H, H-30),
3.59 (ddd, J 9.3, 7.0, 3.0 Hz, 1H, H-50), 3.35 (dd, J
13.5, 6.8 Hz, 1H, H-60a), 3.23 (dd, J 13.5, 3.0 Hz, 1H,
H-60b), 1.99 (s, 3H, Ac), 1.97 (s, 3H, Ac).
169.8 (CO), 137.4 (Cipso), 133.5 (CH@), 128.6, 128.1,
127.8 (Ph), 117.7 (CH2@), 75.2 (C-30), 73.7 (CH2–Ph),
71.3 (C-50), 70.6, 69.5, 68.6 (C-10,20,40), 61.8 (C-60),
32.9 (C-3), 21.0 (Me). Anal. Calcd for C22H28O8: C,
62.85; H, 6.71. Found: C, 62.62; H, 6.84.
1
1.2.10. 3-(30-O-Acetyl-20-N-acetylamino-40,60-di-O-benz-
yl-20-deoxy-a-D-glucopyranosyl)-1-propene (11a). [a]D
+30.0 (c 0.6, CH2Cl2), Rf 0.43 (3:1 EtOAc–cyclohexane);
1H NMR (CDCl3, 250 MHz): d 7.28–7.16 (m, 10H, Ph),
6.15 (d, J 8.8 Hz, 1H, NH), 5.79–5.63 (m, 1H, CH@),
5.07–4.97 (m, 3H, H-30, CH2@), 4.52 (s, 2H, CH2–Ph),
4.51 (d, J 11.8 Hz, 1H, CH–Ph), 4.44 (d, J 12.0 Hz,
1H, CH–Ph), 4.10 (ddd, J 8.8, 6.8, 3.8 Hz, 1H, H-20),
4.03–3.96 (m, 1H, H-10), 3.90 (q, J 5.0 Hz, 1H, H-50),
3.68 (dd, J 10.3, 5.3 Hz, 1H, H-60a), 3.60 (t, J 5.8 Hz,
1H, H-40), 3.56 (dd, J 10.3, 5.3 Hz, 1H, H-60a), 2.35–
2.10 (m, 2H, H-3), 1.89 (s, 3H, Ac), 1.80 (s, 3H, Ac).
13C NMR (CDCl3, 62.9 MHz) d 170.8, 169.9 (CO),
138.0, 137.6 (Cipso), 134.1 (CH@), 128.7, 128.6, 128.2,
127.9 (Ph), 117.4 (CH2@), 73.9 (C-40), 73.5 (C-50,
CH2–Ph), 70.9 (C-30), 70.5 (C-10), 67.9 (C-60), 50.1 (C-
20), 33.4 (C-3), 23.3 (Me), 21.1 (Me). Anal. Calcd for
C27H33NO6: C, 69.36; H, 7.11; N, 3.00. Found: C,
69.55; H, 7.02; N, 2.90.
1.2.7. (20,30,40-Tri-O-acetyl-60-azido-60-deoxy-b-D-gluco-
pyranosyl)-ethene (7c). [a]D +20.3 (c 0.4, CH2Cl2), Rf
0.35 (1:2 EtOAc–cyclohexane); 1H NMR (CDCl3,
250 MHz): 5.81–5.68 (m, 1H, CH@), 5.41–5.30 (m,
2H, CH2@), 5.22 (t, J 9.5 Hz, 1H, H-30), 5.02 (t, J
9.8 Hz, 1H, H-40), 4.92 (t, J 9.5 Hz, 1H, H-20), 3.90
(dd, J 10.0, 6.5 Hz, 1H, H-10), 3.72–3.64 (m, 1H, H-
50), 3.32–3.31 (m, 2H, H-60), 2.03 (s, 3H, Ac), 2.02 (s,
3H, Ac), 2.00 (s, 3H, Ac). 13C NMR (CDCl3,
62.9 MHz): d 170.4, 169.6, 169.5 (CO), 133.0 (CH@),
119.7 (CH2@), 78.9 (C-10), 76.9 (C-50), 73.9 (C-30),
71.4 (C-20), 69.7 (C-40), 51.2 (C-60), 20.7 (Me). Anal.
Calcd for C14H19N3O7: C, 49.27; H, 5.61; N, 12.31.
Found: C, 49.50; H, 5.67; N, 5.50.
1.2.8. 3-(20,40-Di-O-acetyl-30,60-di-O-benzyl-a-D-gluco-
pyranosyl)-1-propene (9a). [a]D +45.0 (c 1, CH2Cl2),
Rf 0.20 (2:3 Et2O–cyclohexane); 1H NMR (CDCl3,
250 MHz): d 7.29–7.16 (m, 10H, Ph), 5.78–5.60 (m, 1H,
CH@), 5.08–4.99 (m, 2H, CH2@), 4.94 (t, J 5.5 Hz, 1H,
H-40), 4.86 (dd, J 6.0, 3.8 Hz, 1H, H-20), 4.58 (s, 2H,
CH2–Ph), 4.44 (s, 2H, CH2–Ph), 4.08–4.00 (m, 1H, H-
10), 3.91 (q, J 5.8 Hz, 1H, H-50), 3.70 (t, J 6.0 Hz, 1H,
H-30), 3.61 (dd, J 10.5, 6.3 Hz, 1H, H-60a), 3.54 (dd, J
10.5, 5.5 Hz, 1H, H-60b), 2.45–2.33 (m, 1H, H-3a),
2.23–2.15 (m, 1H, H-3b), 1.99 (s, 3H, Ac), 1.90 (s, 3H,
Ac). 13C NMR (CDCl3, 62.9 MHz) d 170.1, 169.9
(CO), 137.9 (Cipso), 133.7 (CH@), 128.6, 128.5, 127.9,
127.7 (Ph), 117.7 (CH2@), 75.3 (C-30), 73.5 (CH2–Ph),
72.5 (C-50), 70.6 (C-20), 69.6 (C-10), 69.1 (C-40), 68.5
(C-60), 33.2 (C-3), 21.1 (Me). Anal. Calcd for
C27H32O7: C, 69.21; H, 6.88. Found: C, 69.00; H, 6.95.
1.2.11. 3-(30,60-Di-O-acetyl-20-N-acetylamino-40-O-benz-
yl-20-deoxy-a-D-glucopyranosyl)-1-propene (11b). [a]D
+39.3 (c 0.3, CH2Cl2), Rf 0.33 (3:1 EtOAc–cyclohexane);
1H NMR (CDCl3, 250 MHz) d 7.30–7.23 (m, 5H, Ph),
6.17 (d, J 9.0 Hz, 1H, NH), 5.79–5.63 (m, 1H, CH@),
5.08–4.99 (m, 3H, H-30, CH2@), 4.57 (s, 2H, CH2–Ph),
4.31 (dd, J 11.8, 7.0 Hz, 1H, H-60a), 4.17–4.10 (m, 2H,
H-20,60b), 4.05–3.94 (m, 2H, H-10,50), 3.44 (t, J 4.8 Hz,
1H, H-40), 2.34–2.10 (m, 2H, H-3), 2.01 (s, 3H, Ac),
1.97 (s, 3H, Ac), 1.81 (s, 3H, Ac). 13C NMR (CDCl3,
62.9 MHz): d 170.7, 169.9 (CO), 137.2 (Cipso), 133.9
(CH@), 128.8, 128.4, 128.1 (Ph), 117.6 (CH2@), 73.4
(C-40, CH2–Ph), 72.6 (C-50), 70.3 (C-30), 67.0 (C-10),
61.7 (C-60), 49.7 (C-20), 33.7 (C-3), 23.3 (Me), 21.2
(Me), 20.9 (Me). Anal. Calcd for C22H29NO7: C, 62.99;
H, 6.97; N, 3.34. Found: C, 63.15; H, 7.00; N, 3.26.
1.2.12.
3-(60-Azido-20,30,40-tri-O-benzyl-60-deoxy-a-D-
1.2.9. 3-(20,40,60-Tri-O-acetyl-30-O-benzyl-a-D-glucopyr-
anosyl)-1-propene (9b). [a]D +76.7 (c 0.3, CH2Cl2), Rf
0.11 (2:3 Et2O–cyclohexane); 1H NMR (CDCl3,
250 MHz): d 7.29–7.19 (m, 5H, Ph), 5.76–5.58 (m, 1H,
CH@), 5.07–5.00 (m, 2H, CH2@), 4.90–4.83 (m, 2H,
H-20,40), 4.63 (d, J 11.8 Hz, 1H, CH–Ph), 4.57 (d, J
11.8 Hz, 1H, CH–Ph), 4.35 (dd, J 12.0, 7.0 Hz, 1H, H-
60a), 4.15–4.08 (m, 1H, H-10), 4.02 (dd, J 12.0, 3.8 Hz,
1H, H-60b), 3.91–3.85 (m, 1H, H-50), 3.71 (t, J 6.0 Hz,
1H, H-30), 2.45–2.30 (m, 1H, H-3a), 2.22–2.12 (m, 1H,
H-3b), 2.00 (s, 3H, Ac), 1.99 (s, 3H, Ac), 1.94 (s, 3H,
Ac). 13C NMR (CDCl3, 62.9 MHz): d 170.9, 170.1,
galactopyranosyl)-1-propene (12). This was prepared
following the method described for 4:18 methanesulfonyl
chloride (60 lL, 0.772 mmol) was added to a 0 ꢁC soln
of 3-(20,30,40-tri-O-benzyl-a-D-galactopyranosyl)-1-pro-
pene24 (260 mg, 0.537 mmol) and TEA (137 lL,
0.998 mmol) in CH2Cl2 (2 mL). The ice bath was re-
moved, and stirring was continued for 18 h before
MeOH (50 lL) was added. The soln was concentrated,
dissolved in EtOAc (20 mL) and washed successively
with water, NaHCO3 5% and brine. The organic layer
was dried over MgSO4, filtered and concentrated to an
oil, which was dissolved in DMF (2 mL) and added to